Exercise against nonsmall-cell lung carcinoma: novel insights

被引：0
|
作者：
Plaza-Florido, Abel [1 ]
Fiuza-Luces, Carmen [2 ]
Lucia, Alejandro [2 ,3 ]
机构：
[1] Univ Calif Irvine, Sch Med, Dept Pediat, Pediat Exercise & Genom Res Ctr, Irvine, CA 92717 USA
[2] Hosp 12 Octubre imas12, Phys Exercise & Pediat Canc Res Grp, Res Inst, Madrid, Spain
[3] Univ Europea Madrid, Fac Med Hlth & Sports, Dept Sport Sci, Madrid, Spain
来源：
TRENDS IN CANCER | 2025年 / 11卷 / 01期
关键词：
D O I：
10.1016/j.trecan.2024.11.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The mechanisms underlying the potential 'anticancer' effects of exercise remain poorly understood. Luo et al. recently identified an exercise-induced, muscle-derived extracellular vesicle (EV)-associated miR, miR-29a-3p, as a key player in the potential benefits of exercise against nonsmall-cell lung carcinoma (NSCLC), including extracellular matrix (ECM) inhibition and improved antitumoral immune responses.
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [31] Prognostic impact of intratumoral and stromal lymphocytic infiltrate in nonsmall-cell lung cancer
    Al-Shibli, Khalid
    Donnem, Tom
    Al-Saad, Samer
    Delghandi, Marit
    Persson, Magnus
    Nilsen, Marit
    Bremnes, Roy
    Busund, Lill-Tove
    VIRCHOWS ARCHIV, 2007, 451 (02) : 173 - 174
  • [32] Liensinine Inhibits Cell Growth and Blocks Autophagic Flux in Nonsmall-Cell Lung Cancer
    Chang, Minghui
    Ding, Shanshan
    Dong, Xiaohan
    Shang, Xiaoling
    Li, Yang
    Xie, Li
    Song, Xingguo
    Song, Xianrang
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [33] Is %ΔSUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer?
    Cistaro, Angelina
    Quartuccio, Natale
    Mojtahedi, Alireza
    Fania, Piercarlo
    Filosso, Pier Luigi
    Cucinotta, Mariapaola
    Campenni, Alfredo
    Ficola, Umberto
    Baldari, Sergio
    SCIENTIFIC WORLD JOURNAL, 2013,
  • [34] Maintenance therapy: a new treatment paradigm in advanced nonsmall-cell lung cancer
    Gridelli, Cesare
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (02) : 105 - 106
  • [35] Best supportive care versus palliative chemotherapy in nonsmall-cell lung cancer
    Medley, L
    Cullen, M
    CURRENT OPINION IN ONCOLOGY, 2002, 14 (04) : 384 - 388
  • [36] EXPRESSION OF NSE AND PGP-9.5 IN NONSMALL-CELL LUNG-CANCERS
    WALKER, C
    BURNETT, HE
    KENYON, WE
    SPEDDING, AV
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 6 (01) : 99 - 103
  • [37] Prevalence of in vitro extreme chemotherapy resistance in resected nonsmall-cell lung cancer
    d'Amato, TA
    Landreneau, RJ
    McKenna, RJ
    Santos, RS
    Parker, RJ
    ANNALS OF THORACIC SURGERY, 2006, 81 (02): : 440 - 447
  • [38] A comparison between the expression of tumorigenic LncRNAs in circulating exosomes and the tumor tissue in patients with the nonsmall-cell lung carcinoma: promising findings as to the novel biomarkers
    Zhu, Q.
    Jia, P.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (06): : 1905 - 1917
  • [39] Comparative Atomistic Insights on Apo and ATP-I1171N/S/T in Nonsmall-Cell Lung Cancer
    Balasundaram, Ambritha
    Doss, George Priya C.
    ACS OMEGA, 2023, 8 (46): : 43856 - 43872
  • [40] Genome sequencing for nonsmall-cell lung cancer identifies a basis for nintedanib sensitivity
    Takeda, M.
    Sakai, K.
    Okamoto, K.
    Hayashi, H.
    Tanaka, K.
    Shimizu, T.
    Nishio, K.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2016, 27 (04) : 748 - 750
12345